Supporting women workers in factories: experimental evidence from India

Last registered on May 21, 2024

Pre-Trial

Trial Information

General Information

Title
Supporting women workers in factories: experimental evidence from India
RCT ID
AEARCTR-0013620
Initial registration date
May 20, 2024

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
May 21, 2024, 11:37 AM EDT

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Locations

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Primary Investigator

Affiliation
University of Oxford

Other Primary Investigator(s)

PI Affiliation
PI Affiliation

Additional Trial Information

Status
On going
Start date
2023-12-04
End date
2025-12-31
Secondary IDs
Prior work
This trial does not extend or rely on any prior RCTs.
Abstract
Multinational companies (MNCs) are increasingly implementing social initiatives that aim to improve the health and wellbeing of production workers in their supply chains. Yet, there is limited rigorous evidence on their effectiveness. We collaborate with a large MNC in the apparel sector to conduct a cluster randomised controlled trial (RCT), to study the effects of one such program on outcomes among women employed in Indian factories that are in the MNC's supply chain. This study will evaluate the program's impact on behavioural outcomes, particularly attrition. Additionally, we will investigate the program's effects on self-reported outcomes such as health literacy, health status, and embeddedness in the factory.
External Link(s)

Registration Citation

Citation
Amengual, Matthew , Ishrat Gadhok and Alessandro Guasti. 2024. "Supporting women workers in factories: experimental evidence from India." AEA RCT Registry. May 21. https://doi.org/10.1257/rct.13620-1.0
Experimental Details

Interventions

Intervention(s)
Intervention Start Date
2023-12-07
Intervention End Date
2024-06-01

Primary Outcomes

Primary Outcomes (end points)
retention in the factory; health literacy; health status; and embedded-ness in the factory
Primary Outcomes (explanation)

Secondary Outcomes

Secondary Outcomes (end points)
absenteeism; returning to the factory; job satisfaction; empowerment at home, empowerment at work; subjective wellbeing
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
This is a cluster randomised trial in the supply chain of an MNC. We use administrative data provided by the MNC to draw up a list of factories (clusters) that are eligible for the study. Ultimately, we had a sampling frame of 118 factories producing apparel, textiles, footwear, and accessories. We then sampled 75 factories proportionally to the strata size using the following criteria: size (above and below 500 workers), and geography (north and south).
Experimental Design Details
Not available
Randomization Method
The unit of randomisation of this cluster trial is the factory. To maximise the precision of our estimates, we used a matched quadruplet design following recommendations from the literature. We first calculated the Mahalanobis distance between factories on a set of blocking covariates; we then matched factories that were as similar as possible into quadruplets (18 quadruplets and 1 triplet). We randomly assigned the treatment to two factories in each quadruplet. We did the randomisation in R. Our blocking variables include the stratification variables of geography (North-South) and size, as well as the two factory-level outcomes of interest that we had access to at the time of randomisation: average turnover rates and average absenteeism.
Randomization Unit
factory
Was the treatment clustered?
Yes

Experiment Characteristics

Sample size: planned number of clusters
75 factories
Sample size: planned number of observations
4500 women workers
Sample size (or number of clusters) by treatment arms
38 factories in treatment group, and 37 factories in the control group
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
IRB

Institutional Review Boards (IRBs)

IRB Name
Saïd Business School Departmental Research Ethics Committee (SBS DREC
IRB Approval Date
2023-03-02
IRB Approval Number
SSH_SBS_C1A_23_13
Analysis Plan

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information